Microneedle Patch for Fast Onset and Long-Lasting Delivery of Painkillers

[1]  Christopher L. Wu,et al.  Practice Guidelines for the Prevention, Detection, and Management of Respiratory Depression Associated with Neuraxial Opioid Administration: An Updated Report by the American Society of Anesthesiologists Task Force on Neuraxial Opioids and the American Society of Regional Anesthesia and Pain Medicin , 2017, Anesthesiology.

[2]  K. Koneti,et al.  Management of acute pain , 2013 .

[3]  Lifeng Kang,et al.  A simple method of microneedle array fabrication for transdermal drug delivery , 2013, Drug development and industrial pharmacy.

[4]  N. Miyamoto,et al.  Method to increase the systemically delivered amount of drug from dissolving microneedles. , 2013, Chemical & pharmaceutical bulletin.

[5]  M. Augustin,et al.  Local anesthetic effects of Lidocaine cream: randomized controlled trial using a standardized prick pain , 2012, The Journal of dermatological treatment.

[6]  Jung-Hwan Park,et al.  Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.

[7]  Lifeng Kang,et al.  Protein encapsulation in polymeric microneedles by photolithography , 2012, International journal of nanomedicine.

[8]  G. Mick,et al.  Topical pain management with the 5% lidocaine medicated plaster – a review , 2012, Current medical research and opinion.

[9]  M. Prausnitz,et al.  Rapid Local Anesthesia in Humans Using Minimally Invasive Microneedles , 2012, The Clinical journal of pain.

[10]  A. Comer,et al.  Lidocaine Patch 5% , 2000, Drugs.

[11]  Ying Zhang,et al.  Development of Lidocaine-Coated Microneedle Product for Rapid, Safe, and Prolonged Local Analgesic Action , 2011, Pharmaceutical Research.

[12]  D. Clifford,et al.  Peripheral neuropathy in HIV: prevalence and risk factors , 2011, AIDS.

[13]  Mark R Prausnitz,et al.  Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. , 2011, Diabetes technology & therapeutics.

[14]  C. Sang,et al.  Practice Guidelines for Chronic Pain Management: An Updated Report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine* , 2010, Anesthesiology.

[15]  J. Fleming,et al.  Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre. , 2009, Pain research & management.

[16]  Jung-Hwan Park,et al.  Dissolving microneedles for transdermal drug delivery. , 2008, Biomaterials.

[17]  Mark R Prausnitz,et al.  Microneedles permit transdermal delivery of a skin-impermeant medication to humans , 2008, Proceedings of the National Academy of Sciences.

[18]  John P Fisher,et al.  Synthesis and characterization of cyclic acetal based degradable hydrogels. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  B. Collett,et al.  Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment , 2006, European journal of pain.

[20]  S. G. Frank,et al.  Characterization of supersaturated lidocaine/polyacrylate pressure sensitive adhesive systems: thermal analysis and FT-IR. , 2006, Journal of pharmaceutical sciences.

[21]  J. Reimer-Kent.  Improving post-operative pain management by focusing on prevention. , 2004, Nursing BC.

[22]  J. Bogousslavsky,et al.  Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study , 2003, Pain.

[23]  M. Rowbotham,et al.  Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study , 1999, Pain.

[24]  M. Rowbotham,et al.  Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia , 1996, Pain.